<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl4">
 <label>Table 4</label>
 <caption>
  <p>ADME/T prediction of selected bioactives from HMP</p>
 </caption>
 <alt-text id="alttext0010a">Table 4</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Class</th>
    <th>Properties</th>
    <th>6,6' Biapigenin</th>
    <th>Candibirin G</th>
    <th>Candibirin H</th>
    <th>Catechin 5-O-gallate</th>
    <th>Hypericin</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="5" align="left">
     <bold>Absorption</bold>
    </td>
    <td align="left">Caco-2 permeability (&gt; -5.15 cm/s)</td>
    <td align="left">Not optimal
     <break/>-6.351 cm/s
    </td>
    <td align="left">Optimal
     <break/>-5.06 cm/s
    </td>
    <td align="left">Optimal
     <break/>-5.06 cm/s
    </td>
    <td align="left">Not optimal
     <break/>-6.716 cm/s
    </td>
    <td align="left">Not optimal
     <break/>-6.277 cm/s
    </td>
   </tr>
   <tr>
    <td align="left">Pgp-inhibitor</td>
    <td align="left">+
     <break/>0.649
    </td>
    <td align="left">++
     <break/>0.863
    </td>
    <td align="left">++
     <break/>0.863
    </td>
    <td align="left">++
     <break/>0.727
    </td>
    <td align="left">---
     <break/>0.04
    </td>
   </tr>
   <tr>
    <td align="left">Pgp-substrate</td>
    <td align="left">---
     <break/>0.022
    </td>
    <td align="left">---
     <break/>0.166
    </td>
    <td align="left">---
     <break/>0.166
    </td>
    <td align="left">---
     <break/>0.044
    </td>
    <td align="left">---
     <break/>0.071
    </td>
   </tr>
   <tr>
    <td align="left">HIA (Human Intestinal Absorption)
     <break/>(≥30%: HIA+; &lt;30%: HIA-)
    </td>
    <td align="left">-
     <break/>0.43
    </td>
    <td align="left">+
     <break/>0.5
    </td>
    <td align="left">+
     <break/>0.5
    </td>
    <td align="left">-
     <break/>0.355
    </td>
    <td align="left">-
     <break/>0.499
    </td>
   </tr>
   <tr>
    <td align="left">F (20% Bioavailability)
     <break/>(≥20%: F20+; &lt;20%: F20-)
    </td>
    <td align="left">+
     <break/>0.572
    </td>
    <td align="left">-
     <break/>0.434
    </td>
    <td align="left">-
     <break/>0.434
    </td>
    <td align="left">+
     <break/>0.522
    </td>
    <td align="left">+
     <break/>0.616
    </td>
   </tr>
   <tr>
    <td rowspan="3" align="left">
     <bold>Distribution</bold>
    </td>
    <td align="left">PPB (Plasma Protein Binding)
     <break/>(90%)
    </td>
    <td align="left">83.574 %</td>
    <td align="left">82.842 %</td>
    <td align="left">82.842 %</td>
    <td align="left">86.718 %</td>
    <td align="left">79.862 %</td>
   </tr>
   <tr>
    <td align="left">Volume distribution (0.04∼20 L/kg)</td>
    <td align="left">-0.821 L/kg</td>
    <td align="left">-0.169 L/kg</td>
    <td align="left">-0.169 L/kg</td>
    <td align="left">-1.187 L/kg</td>
    <td align="left">-1.026 L/kg</td>
   </tr>
   <tr>
    <td align="left">BBB (Blood–Brain Barrier)
     <break/>(BB ratio &gt;=0.1: BBB+; BB ratio &lt;0.1: BBB-)
    </td>
    <td align="left">---
     <break/>0.236
    </td>
    <td align="left">-
     <break/>0.38
    </td>
    <td align="left">-
     <break/>0.38
    </td>
    <td align="left">++
     <break/>0.736
    </td>
    <td align="left">++
     <break/>0.885
    </td>
   </tr>
   <tr>
    <td rowspan="10" align="left">
     <bold>Metabolism</bold>
    </td>
    <td align="left">P450 CYP1A2 inhibitor</td>
    <td align="left">++
     <break/>0.812
    </td>
    <td align="left">---
     <break/>0.15
    </td>
    <td align="left">---
     <break/>0.15
    </td>
    <td align="left">---
     <break/>0.099
    </td>
    <td align="left">++
     <break/>0.848
    </td>
   </tr>
   <tr>
    <td align="left">P450 CYP1A2 substrate</td>
    <td align="left">-
     <break/>0.428
    </td>
    <td align="left">-
     <break/>0.488
    </td>
    <td align="left">-
     <break/>0.488
    </td>
    <td align="left">-
     <break/>0.424
    </td>
    <td align="left">-
     <break/>0.444
    </td>
   </tr>
   <tr>
    <td align="left">P450 CYP3A4 inhibitor</td>
    <td align="left">++
     <break/>0.827
    </td>
    <td align="left">++
     <break/>0.847
    </td>
    <td align="left">++
     <break/>0.847
    </td>
    <td align="left">-
     <break/>0.312
    </td>
    <td align="left">---
     <break/>0.042
    </td>
   </tr>
   <tr>
    <td align="left">P450 CYP3A4 substrate</td>
    <td align="left">-
     <break/>0.458
    </td>
    <td align="left">+
     <break/>0.674
    </td>
    <td align="left">+
     <break/>0.674
    </td>
    <td align="left">+
     <break/>0.532
    </td>
    <td align="left">-
     <break/>0.336
    </td>
   </tr>
   <tr>
    <td align="left">P450 CYP2C9 inhibitor</td>
    <td align="left">---
     <break/>0.156
    </td>
    <td align="left">+
     <break/>0.517
    </td>
    <td align="left">+
     <break/>0.517
    </td>
    <td align="left">---
     <break/>0.251
    </td>
    <td align="left">---
     <break/>0.116
    </td>
   </tr>
   <tr>
    <td align="left">P450 CYP2C9 substrate</td>
    <td align="left">+
     <break/>0.619
    </td>
    <td align="left">-
     <break/>0.352
    </td>
    <td align="left">-
     <break/>0.352
    </td>
    <td align="left">-
     <break/>0.488
    </td>
    <td align="left">-
     <break/>0.398
    </td>
   </tr>
   <tr>
    <td align="left">P450 CYP2C19 inhibitor</td>
    <td align="left">---
     <break/>0.116
    </td>
    <td align="left">---
     <break/>0.2
    </td>
    <td align="left">---
     <break/>0.2
    </td>
    <td align="left">+
     <break/>0.568
    </td>
    <td align="left">---
     <break/>0.119
    </td>
   </tr>
   <tr>
    <td align="left">P450 CYP2C19 substrate</td>
    <td align="left">-
     <break/>0.403
    </td>
    <td align="left">-
     <break/>0.469
    </td>
    <td align="left">-
     <break/>0.469
    </td>
    <td align="left">-
     <break/>0.404
    </td>
    <td align="left">-
     <break/>0.496
    </td>
   </tr>
   <tr>
    <td align="left">P450 CYP2D6 inhibitor</td>
    <td align="left">-
     <break/>0.455
    </td>
    <td align="left">+
     <break/>0.513
    </td>
    <td align="left">+
     <break/>0.513
    </td>
    <td align="left">-
     <break/>0.404
    </td>
    <td align="left">---
     <break/>0.235
    </td>
   </tr>
   <tr>
    <td align="left">P450 CYP2D6 substrate</td>
    <td align="left">-
     <break/>0.484
    </td>
    <td align="left">-
     <break/>0.425
    </td>
    <td align="left">-
     <break/>0.425
    </td>
    <td align="left">+
     <break/>0.517
    </td>
    <td align="left">-
     <break/>0.322
    </td>
   </tr>
   <tr>
    <td rowspan="2" align="left">
     <bold>Excretion</bold>
    </td>
    <td align="left">T 
     <sub>1/2</sub> (Half Life Time)
     <break/>( &gt;8h: high;
     <break/>3h&lt; Cl &lt; 8h: moderate;
     <break/>&lt;3h: low)
    </td>
    <td align="left">Low
     <break/>2.432 h
    </td>
    <td align="left">Low
     <break/>2.044 h
    </td>
    <td align="left">Low
     <break/>2.044 h
    </td>
    <td align="left">Low
     <break/>1.494 h
    </td>
    <td align="left">Moderate
     <break/>3.306 h
    </td>
   </tr>
   <tr>
    <td align="left">Clearance rate (&gt;15 mL/min/kg:high; 5mL/min/kg&lt; Cl &lt; 15mL/min/kg: moderate;
     <break/>&lt;5 mL/min/kg: low)
    </td>
    <td align="left">Low
     <break/>1.177 mL/min/kg
    </td>
    <td align="left">Low
     <break/>1.103 mL/min/kg
    </td>
    <td align="left">Low
     <break/>1.103 mL/min/kg
    </td>
    <td align="left">Low
     <break/>1.201 mL/min/kg
    </td>
    <td align="left">Low
     <break/>0.671 mL/min/kg
    </td>
   </tr>
   <tr>
    <td rowspan="5" align="left">
     <bold>Toxicity</bold>
    </td>
    <td align="left">hERG (hERG Blockers)</td>
    <td align="left">+
     <break/>0.666
    </td>
    <td align="left">++
     <break/>0.722
    </td>
    <td align="left">++
     <break/>0.722
    </td>
    <td align="left">+
     <break/>0.662
    </td>
    <td align="left">-
     <break/>0.494
    </td>
   </tr>
   <tr>
    <td align="left">H-HT (Human Hepatotoxicity)</td>
    <td align="left">---
     <break/>0.248
    </td>
    <td align="left">+
     <break/>0.528
    </td>
    <td align="left">+
     <break/>0.528
    </td>
    <td align="left">-
     <break/>0.366
    </td>
    <td align="left">---
     <break/>0.182
    </td>
   </tr>
   <tr>
    <td align="left">Ames (Ames Mutagenicity)</td>
    <td align="left">-
     <break/>0.388
    </td>
    <td align="left">---
     <break/>0.298
    </td>
    <td align="left">---
     <break/>0.298
    </td>
    <td align="left">-
     <break/>0.47
    </td>
    <td align="left">---
     <break/>0.292
    </td>
   </tr>
   <tr>
    <td align="left">Skin sensitization</td>
    <td align="left">---
     <break/>0.282
    </td>
    <td align="left">---
     <break/>0.263
    </td>
    <td align="left">---
     <break/>0.263
    </td>
    <td align="left">---
     <break/>0.271
    </td>
    <td align="left">-
     <break/>0.313
    </td>
   </tr>
   <tr>
    <td align="left">FDAMDD (Maximum Recommended Daily Dose</td>
    <td align="left">+
     <break/>0.608
    </td>
    <td align="left">---
     <break/>0.272
    </td>
    <td align="left">---
     <break/>0.272
    </td>
    <td align="left">+
     <break/>0.624
    </td>
    <td align="left">+
     <break/>0.674
    </td>
   </tr>
  </tbody>
 </table>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Class</th>
    <th>Properties</th>
    <th>Pseudohypericin</th>
    <th>Kaempferol 3-glucoside 7-rhamnoside</th>
    <th>Kaempferol 7,4 diglucoside</th>
    <th>Tribuloside</th>
    <th>Tribulosin</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="5" align="left">
     <bold>Absorption</bold>
    </td>
    <td align="left">Caco-2 permeability (&gt; -5.15 cm/s)</td>
    <td align="left">Not optimal
     <break/>-6.466 cm/s
    </td>
    <td align="left">Not optimal
     <break/>-6.485 cm/s
    </td>
    <td align="left">Not optimal
     <break/>-6.651 cm/s
    </td>
    <td align="left">Not optimal
     <break/>-6.433 cm/s
    </td>
    <td align="left">Not optimal
     <break/>-6.417 cm/s
    </td>
   </tr>
   <tr>
    <td align="left">Pgp-inhibitor</td>
    <td align="left">---
     <break/>0.06
    </td>
    <td align="left">-
     <break/>0.401
    </td>
    <td align="left">-
     <break/>0.393
    </td>
    <td align="left">++
     <break/>0.723
    </td>
    <td align="left">++
     <break/>0.802
    </td>
   </tr>
   <tr>
    <td align="left">Pgp-substrate</td>
    <td align="left">---
     <break/>0.101
    </td>
    <td align="left">---
     <break/>0.053
    </td>
    <td align="left">---
     <break/>0.011
    </td>
    <td align="left">---
     <break/>0.039
    </td>
    <td align="left">---
     <break/>0.082
    </td>
   </tr>
   <tr>
    <td align="left">HIA (Human Intestinal Absorption)
     <break/>(≥30%: HIA+; &lt;30%: HIA-)
    </td>
    <td align="left">-
     <break/>0.427
    </td>
    <td align="left">---
     <break/>0.184
    </td>
    <td align="left">---
     <break/>0.107
    </td>
    <td align="left">---
     <break/>0.127
    </td>
    <td align="left">---
     <break/>0.162
    </td>
   </tr>
   <tr>
    <td align="left">F (20% Bioavailability)</td>
    <td align="left">+
     <break/>0.559
    </td>
    <td align="left">+
     <break/>0.56
    </td>
    <td align="left">-
     <break/>0.451
    </td>
    <td align="left">-
     <break/>0.443
    </td>
    <td align="left">---
     <break/>0.26
    </td>
   </tr>
   <tr>
    <td rowspan="3" align="left">
     <bold>Distribution</bold>
    </td>
    <td align="left">PPB (Plasma Protein Binding)
     <break/>(90%)
    </td>
    <td align="left">80.653 %</td>
    <td align="left">75.785 %</td>
    <td align="left">75.492 %</td>
    <td align="left">85.891 %</td>
    <td align="left">50.279 %</td>
   </tr>
   <tr>
    <td align="left">Volume distribution (0.04∼20 L/kg)</td>
    <td align="left">
     <break/>-0.719 L/kg
    </td>
    <td align="left">
     <break/>-1.06 L/kg
    </td>
    <td align="left">
     <break/>-1.092 L/kg
    </td>
    <td align="left">-0.733 L/kg</td>
    <td align="left">
     <break/>-0.574 L/kg
    </td>
   </tr>
   <tr>
    <td align="left">BBB (Blood–Brain Barrier)
     <break/>(BB ratio&gt;=0.1: BBB+; BB ratio &lt;0.1: BBB-)
    </td>
    <td align="left">++
     <break/>0.709
    </td>
    <td align="left">---
     <break/>0.015
    </td>
    <td align="left">---
     <break/>0.098
    </td>
    <td align="left">---
     <break/>0.04
    </td>
    <td align="left">---
     <break/>0.162
    </td>
   </tr>
   <tr>
    <td rowspan="10" align="left">
     <bold>Metabolism</bold>
    </td>
    <td align="left">P450 CYP1A2 inhibitor</td>
    <td align="left">+
     <break/>0.657
    </td>
    <td align="left">---
     <break/>0.158
    </td>
    <td align="left">---
     <break/>0.127
    </td>
    <td align="left">---
     <break/>0.288
    </td>
    <td align="left">---
     <break/>0.061
    </td>
   </tr>
   <tr>
    <td align="left">P450 CYP1A2 substrate</td>
    <td align="left">-
     <break/>0.438
    </td>
    <td align="left">---
     <break/>0.228
    </td>
    <td align="left">---
     <break/>0.178
    </td>
    <td align="left">---
     <break/>0.257
    </td>
    <td align="left">---
     <break/>0.266
    </td>
   </tr>
   <tr>
    <td align="left">P450 CYP3A4 inhibitor</td>
    <td align="left">---
     <break/>0.11
    </td>
    <td align="left">---
     <break/>0.151
    </td>
    <td align="left">---
     <break/>0.072
    </td>
    <td align="left">+
     <break/>0.615
    </td>
    <td align="left">+
     <break/>0.509
    </td>
   </tr>
   <tr>
    <td align="left">P450 CYP3A4 substrate</td>
    <td align="left">-
     <break/>0.44
    </td>
    <td align="left">-
     <break/>0.366
    </td>
    <td align="left">-
     <break/>0.31
    </td>
    <td align="left">-
     <break/>0.372
    </td>
    <td align="left">-
     <break/>0.495
    </td>
   </tr>
   <tr>
    <td align="left">P450 CYP2C9 inhibitor</td>
    <td align="left">---
     <break/>0.131
    </td>
    <td align="left">---
     <break/>0.158
    </td>
    <td align="left">---
     <break/>0.109
    </td>
    <td align="left">-
     <break/>0.398
    </td>
    <td align="left">-
     <break/>0.431
    </td>
   </tr>
   <tr>
    <td align="left">P450 CYP2C9 substrate</td>
    <td align="left">-
     <break/>0.361
    </td>
    <td align="left">-
     <break/>0.366
    </td>
    <td align="left">-
     <break/>0.481
    </td>
    <td align="left">-
     <break/>0.469
    </td>
    <td align="left">---
     <break/>0.218
    </td>
   </tr>
   <tr>
    <td align="left">P450 CYP2C19 inhibitor</td>
    <td align="left">---
     <break/>0.09
    </td>
    <td align="left">---
     <break/>0.07
    </td>
    <td align="left">---
     <break/>0.075
    </td>
    <td align="left">---
     <break/>0.268
    </td>
    <td align="left">---
     <break/>0.088
    </td>
   </tr>
   <tr>
    <td align="left">P450 CYP2C19 substrate</td>
    <td align="left">+
     <break/>0.51
    </td>
    <td align="left">-
     <break/>0.405
    </td>
    <td align="left">-
     <break/>0.35
    </td>
    <td align="left">-
     <break/>0.322
    </td>
    <td align="left">-
     <break/>0.378
    </td>
   </tr>
   <tr>
    <td align="left">P450 CYP2D6 inhibitor</td>
    <td align="left">-
     <break/>0.332
    </td>
    <td align="left">-
     <break/>0.351
    </td>
    <td align="left">-
     <break/>0.323
    </td>
    <td align="left">-
     <break/>0.406
    </td>
    <td align="left">-
     <break/>0.334
    </td>
   </tr>
   <tr>
    <td align="left">P450 CYP2D6 substrate</td>
    <td align="left">-
     <break/>0.333
    </td>
    <td align="left">---
     <break/>0.276
    </td>
    <td align="left">-
     <break/>0.305
    </td>
    <td align="left">-
     <break/>0.345
    </td>
    <td align="left">---
     <break/>0.275
    </td>
   </tr>
   <tr>
    <td rowspan="2" align="left">
     <bold>Excretion</bold>
    </td>
    <td align="left">T 
     <sub>1/2</sub> (Half Life Time)
     <break/>( &gt;8h: high;
     <break/>3h&lt; Cl &lt; 8h: moderate;
     <break/>&lt;3h: low)
    </td>
    <td align="left">Moderate
     <break/>3.042 h
    </td>
    <td align="left">Low
     <break/>2.09 h
    </td>
    <td align="left">Low
     <break/>2.194 h
    </td>
    <td align="left">Low
     <break/>2.299 h
    </td>
    <td align="left">Low
     <break/>2.70 h
    </td>
   </tr>
   <tr>
    <td align="left">Clearance rate (&gt;15 mL/min/kg:high; 5mL/min/kg&lt; Cl &lt; 15mL/min/kg: moderate;
     <break/>&lt;5 mL/min/kg: low)
    </td>
    <td align="left">Low
     <break/>0.212 mL/min/kg
    </td>
    <td align="left">Low
     <break/>0.701 mL/min/kg
    </td>
    <td align="left">Low
     <break/>0.656 mL/min/kg
    </td>
    <td align="left">Low
     <break/>0.998 mL/min/kg
    </td>
    <td align="left">Low
     <break/>0.189 mL/min/kg
    </td>
   </tr>
   <tr>
    <td rowspan="5" align="left">
     <bold>Toxicity</bold>
    </td>
    <td align="left">hERG (hERG Blockers)</td>
    <td align="left">+
     <break/>0.511
    </td>
    <td align="left">+
     <break/>0.582
    </td>
    <td align="left">+
     <break/>0.648
    </td>
    <td align="left">+
     <break/>0.672
    </td>
    <td align="left">+
     <break/>0.664
    </td>
   </tr>
   <tr>
    <td align="left">H-HT (Human Hepatotoxicity)</td>
    <td align="left">---
     <break/>0.072
    </td>
    <td align="left">---
     <break/>0.212
    </td>
    <td align="left">---
     <break/>0.17
    </td>
    <td align="left">-
     <break/>0.314
    </td>
    <td align="left">---
     <break/>0.0
    </td>
   </tr>
   <tr>
    <td align="left">Ames (Ames Mutagenicity)</td>
    <td align="left">++
     <break/>0.788
    </td>
    <td align="left">+
     <break/>0.646
    </td>
    <td align="left">-
     <break/>0.478
    </td>
    <td align="left">+
     <break/>0.672
    </td>
    <td align="left">---
     <break/>0.236
    </td>
   </tr>
   <tr>
    <td align="left">Skin sensitization</td>
    <td align="left">---
     <break/>0.288
    </td>
    <td align="left">---
     <break/>0.236
    </td>
    <td align="left">---
     <break/>0.261
    </td>
    <td align="left">---
     <break/>0.293
    </td>
    <td align="left">---
     <break/>0.258
    </td>
   </tr>
   <tr>
    <td align="left">FDAMDD (Maximum Recommended Daily Dose</td>
    <td align="left">+
     <break/>0.668
    </td>
    <td align="left">+
     <break/>0.602
    </td>
    <td align="left">+
     <break/>0.628
    </td>
    <td align="left">+
     <break/>0.544
    </td>
    <td align="left">-
     <break/>0.37
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
